QRT‐PCR is considered excellent in monitoring patients with CML and indicating the level of presence and quantity of the BCR‐ABL1 gene through the detection of MMR and DMR. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.